[news] Xencor to Present Phase 1 Data on XmAb®2513 Antibody for Lymphomas at the American Society of Clinical Oncology Annual Meeting

Xencor will present Phase 1 Data on XmAb®2513 Antibody for Lymphomas

2009, May

http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20090515005115&newsLang=en